Presentation box and contents
Latest Glaxo Group Limited Patents:
- Method of producing a recombinant protein
- Antigen binding proteins
- Pharmaceutical formulations comprising 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl) phenol
- Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor agonist
- Compounds
Description
FIG. 1 is a perspective view of a presentation box and article showing our new design;
FIG. 2 is a bottom plan view thereof;
FIG. 3 is a top plan view thereof;
FIG. 4 is a side elevation view thereof;
FIG. 5 is an elevation view of one end thereof; and
FIG. 6 is an elevation view of the other end thereof.
Referenced Cited
U.S. Patent Documents
Patent History
Patent number: D314335
Type: Grant
Filed: Apr 3, 1990
Date of Patent: Feb 5, 1991
Assignee: Glaxo Group Limited (London)
Inventors: Robert E. Newell (Pinner), Paul K. Rand (Hitchin)
Primary Examiner: Bernard Ansher
Assistant Examiner: Prabharar Deshmukh
Law Firm: Darby & Darby
Application Number: 7/504,429
Type: Grant
Filed: Apr 3, 1990
Date of Patent: Feb 5, 1991
Assignee: Glaxo Group Limited (London)
Inventors: Robert E. Newell (Pinner), Paul K. Rand (Hitchin)
Primary Examiner: Bernard Ansher
Assistant Examiner: Prabharar Deshmukh
Law Firm: Darby & Darby
Application Number: 7/504,429
Classifications
Current U.S. Class:
D/9418